Immunological abnormalities associated with hereditary haemorrhagic telangiectasia

Journal of Internal Medicine

Volumn 274, Issue 4, 2013, Pages 351-362

  Guilhem, A ^a   Malcus, C ^b   Clarivet, B ^c   Plauchu, H ^d   Dupuis Girod, S ^d  

^a HÔPITAL SAINT ELOI   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c Montpellier 1 University   (France)

^d LOUIS PRADEL HOSPITAL   (France)

Author keywords

Hereditary hemorrhagic telangiectasia; Immunoglobulins M; Immunologic deficiency syndromes; T lymphocytopenia

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOLOGY; INFECTION RATE; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MALE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERIOVENOUS FISTULA; RENDU OSLER WEBER DISEASE; RESPIRATORY BURST; T LYMPHOCYTE; VITAMIN SUPPLEMENTATION;

HEREDITARY HEMORRHAGIC TELANGIECTASIA; IMMUNOGLOBULINS M; IMMUNOLOGIC DEFICIENCY SYNDROMES; T LYMPHOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNITY, INNATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LYMPHOPENIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; YOUNG ADULT;

EID: 84883741856     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12098     Document Type: Article

References (33)

1. Dupuis-Girod S, Bailly S, Plauchu H. Hereditary hemorrhagic telangiectasia: from molecular biology to patient care. J Thromb Haemost 2010; 8: 1447-56.
2. Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 2009; 17: 860-71.
3. David L, Mallet C, Mazerbourg S, Feige J-J, Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 2007; 109: 1953-61.
4. Bailly S, Dupuis-Girod S, Plauchu H. Rendu-Osler disease: clinical and molecular update. Med Sci (Paris) 2010; 26: 855-60.
5. David L, Mallet C, Keramidas M et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 2008; 102: 914-22.
6. Duval X, Djendli S, Le Moing V et al. Recurrent Staphylococcus aureus extracerebral infections complicating hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease). Am J Med 2001; 110: 671-2.
7. Sell B, Evans J, Horn D. Brain abscess and hereditary hemorrhagic telangiectasia. South Med J 2008; 101: 618-25.
8. Bui E, Gorse A, Prelipcean V et al. Maladie de Rendu-Osler et abcès hépatique. Médecine et Maladies Infectiouses 2010; 40: 42-4.
9. Dupuis-Girod S, Giraud S, Decullier E et al. Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases: an underestimated association. Clin Infect Dis 2007; 44: 841-5.
10. Sanz-Rodriguez F, Fernandez-L A, Zarrabeitia R et al. Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes. Clin Chem 2004; 50: 2003-11.
11. Schmidt-Weber CB, Letarte M, Kunzmann S, Rückert B, Bernabéu C, Blaser K. TGF-{beta} signaling of human T cells is modulated by the ancillary TGF-β receptor endoglin. Int Immunol 2005; 17: 921-30.
12. Cirulli A, Loria MP, Dambra P et al. Patients with Hereditary Hemorrhagic Telangiectasia (HHT) exhibit a deficit of polymorphonuclear cell and monocyte oxidative burst and phagocytosis: a possible correlation with altered adaptive immune responsiveness in HHT. Curr Pharm Des 2006; 12: 1209-15.
13. Shovlin CL, Guttmacher AE, Buscarini E et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91: 66-7.
14. Berezné A, Bono W, Guillevin L, Mouthon L. Diagnosis of lymphocytopenia. Presse Med 2006; 35: 895-902.
15. Paino IMM, Miranda JC, Marzocchi-Machado CM, Cesarino EJ, De Castro FA, De Souza AM. Phagocytosis, oxidative burst, and produced reactive species are affected by iron deficiency anemia and anemia of chronic diseases in elderly. Biol Trace Elem Res 2009; 129: 116-25.
16. Ekiz C, Agaoglu L, Karakas Z, Gurel N, Yalcin I. The effect of iron deficiency anemia on the function of the immune system. Hematol J 2005; 5: 579-83.
17. Lim PS, Wei YH, Yu YL, Kho B. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. Nephrol Dial Transplant 1999; 14: 2680-7.
18. Tiwari AKM, Mahdi AA, Chandyan S et al. Oral iron supplementation leads to oxidative imbalance in anemic women: a prospective study. Clin Nutr 2011; 30: 188-93.
19. Steensberg A, Morrow J, Toft AD, Bruunsgaard H, Pedersen BK. Prolonged exercise, lymphocyte apoptosis and F2-isoprostanes. Eur J Appl Physiol 2002; 87: 38-42.
20. Tanimura Y, Shimizu K, Tanabe K et al. Exercise-induced oxidative DNA damage and lymphocytopenia in sedentary young males. Med Sci Sports Exerc 2008; 40: 1455-62.
21. Young K, Conley B, Romero D et al. BMP9 regulates endoglin-dependent chemokine responses in endothelial cells. Blood 2012; 120: 4263-73.
22. Post S, Smits AM, Van den Broek AJ et al. Impaired recruitment of HHT-1 mononuclear cells to the ischaemic heart is due to an altered CXCR4/CD26 balance. Cardiovasc Res 2010; 85: 494-502.
23. Kucia M, Jankowski K, Reca R et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 2004; 35: 233-45.
24. Cottin V, Chinet T, Lavolé A et al. Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients. Medicine (Baltimore) 2007; 86: 1-17.
25. Shovlin CL, Jackson JE, Bamford KB et al. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 2008; 63: 259-66.
26. Suchanek O, Sadler R, Bateman EA, Patel SY, Ferry BL. Immunophenotyping of putative human B1 B cells in healthy controls and common variable immunodeficiency (CVID) patients. Clin Exp Immunol 2012; 170: 333-41.
27. Racine R, Winslow GM. IgM in microbial infections: taken for granted? Immunol Lett 2009; 125: 79-85.
28. Boes M. Role of natural and immune IgM antibodies in immune responses. Mol Immunol 2000; 37: 1141-9.
29. Belgemen T, Suskan E, Dogu F, Ikinciogullari A. Selective immunoglobulin M deficiency presenting with recurrent impetigo: a case report and review of the literature. Int Arch Allergy Immunol 2009; 149: 283-8.
30. Yel L, Ramanuja S, Gupta S. Clinical and immunological features in IgM deficiency. Int Arch Allergy Immunol 2009; 150: 291-8.
31. Carsetti R, Rosado MM, Donnanno S et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 2005; 115: 412-7.
32. De Vries E. Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists. Clin Exp Immunol 2006; 145: 204-14.
33. Abraham RS. Relevance of laboratory testing for the diagnosis of primary immunodeficiencies: a review of case-based examples of selected immunodeficiencies. Clin Mol Allergy 2011; 9: 6.